Thorsten Leucker (@tleucker) 's Twitter Profile
Thorsten Leucker

@tleucker

Preventive and Critical Care Cardiologist, Vascular Biologist, Director, Cardiology Fellowship Program @HopkinsMedicine

ID: 1164867553266524161

calendar_today23-08-2019 11:50:52

122 Tweet

841 Takipçi

307 Takip Edilen

Johns Hopkins Cardiology (@hopkinsheart) 's Twitter Profile Photo

2023 Holiday Party 🎄 A little glimpse of our white elephant gift exchange 🎁.. great gifts all around, from cold hard cash 💵 to children’s ECMO books 📚(gotta teach them young🫀)

2023 Holiday Party 🎄 
A little glimpse of our white elephant gift exchange 🎁.. great gifts all around, from cold hard cash 💵 to children’s ECMO books 📚(gotta teach them young🫀)
Joseph Goldenberg, MD PhD (@jr_goldenberg) 's Twitter Profile Photo

Better preserved myocardial energetics detected by non-invasive cardiac 31P MRS in HFrEF predicts future LVEF recovery, LV reverse remodeling, and clinical hard outcomes (cardiac death, LVAD, or transplant). Our paper just out in Circulation! ahajournals.org/doi/10.1161/CI…

Johns Hopkins Cardiology (@hopkinsheart) 's Twitter Profile Photo

A little Women in Cardiology fun tonight 🫀🎉 Raising each other up 😍 while knocking some pins down 🎳 Thanks for arranging an awesome event Anjali 🤩

A little Women in Cardiology fun tonight 🫀🎉 
Raising each other up 😍 while knocking some pins down 🎳 
Thanks for arranging an awesome event <a href="/Anjali_Wagle/">Anjali</a> 🤩
EHJOpen Editor-in-Chief (@ehjopen) 's Twitter Profile Photo

Curious about the impact of Lp(a) on #cardiovascular risk? check the #ESCCongress session: esc365.escardio.org/ESC-Congress/s… simultaneous publication on #EHJOpen: doi.org/10.1093/ehjope… #OpenUpYourScience European Society of Cardiology Journals Salvatore De Rosa Magnus Bäck Thorsten Leucker Maciej Banach SABOURETCardiologist

Taher Modarressi, M.D. (@tmodarressi) 's Twitter Profile Photo

Is it time we routinely remeasure Lp(a) for those w initial levels in the traditional “grey zone” (30-50 mg/dL, 75-125 nmol/L)? Surprising amount of intraindividual variability, and repeat msmt reclassified risk in 53% of pts. Excellent data from Tarek Harb at #ESCCongress2024

Is it time we routinely remeasure Lp(a) for those w initial levels in the traditional “grey zone” (30-50 mg/dL, 75-125 nmol/L)? Surprising amount of intraindividual variability, and repeat msmt reclassified risk in 53% of pts. Excellent data from <a href="/TarekHarbMD/">Tarek Harb</a> at #ESCCongress2024
Thorsten Leucker (@tleucker) 's Twitter Profile Photo

Thank you, Maciej Banach, for your outstanding editorial and thoughtful summary of our work on Lp(a) variability. Your insights and comprehensive overview of the current, albeit sparse, literature on this topic are invaluable. EHJOpen Editor-in-Chief Tarek Harb

Thorsten Leucker (@tleucker) 's Twitter Profile Photo

👉🏻Our study suggests repeat Lp(a) tests 🧪could be crucial for those in the #society_eas intermediate risk group. 53% could be reclassified with a second test. Time to rethink cardiovascular risk assessment. European Atherosclerosis Society EHJOpen Editor-in-Chief American Heart Association American College of Cardiology Tarek Harb

Thorsten Leucker (@tleucker) 's Twitter Profile Photo

🔥 Following up on Tarek Harb’s fantastic presentation on intraindividual variability in #lpa doi.org/10.1093/ehjope… at #ESC2024, today he delved into 🧬 PPAR-gamma's regulation of Lp(a) gene expression in HepG2 cells. Sam Tsimikas, MD Paul Mason MD Maciej Banach National Lipid Association

🔥 Following up on <a href="/TarekHarbMD/">Tarek Harb</a>’s fantastic presentation on intraindividual variability in #lpa doi.org/10.1093/ehjope… at #ESC2024, today he delved into 🧬 PPAR-gamma's regulation of Lp(a) gene expression in HepG2 cells. <a href="/Lpa_Doc/">Sam Tsimikas, MD</a> <a href="/DrPaulMason/">Paul Mason MD</a> <a href="/maciejbanach/">Maciej Banach</a> <a href="/nationallipid/">National Lipid Association</a>